Biology Reference
In-Depth Information
69. Ader R, Cohen N. Conditioning of immune response. Neth J Med 1991;39:263-73.
70. Brosschot JF, Benschop RJ, Godaert GLR, Olff M, De Smet M, Heijnen CJ, et al.
Influence of life stress on immunological reactivity to mild psychological stress.
Psychosom Med 1994;56:216-24.
71. Benschop RJ, Godaert GRL, Geenen R, Brosschot JF, De Smet M, Olff M, et al.
Relationship between cardiovascular and immunological changes in an experimental
stress model. Psychol Med 1995;25:323-27.
72. Herbert TB, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom
Med 1993;55:364-79.
73. Kielsot-Glaser JK, Glaser R. Psychoneuroimmunology and health consequences: data and
shared mechanisms. Psychosom Med 1995;57:269-74.
74. Koh KB, Lee BK. Reduced lymphocyte proliferation and interleukin-2 production in anxi-
ety disorders. Psychosom Med 1998;60:479-83.
75. Song C, Kenis G, Van Gastel A, Bosmans E, Lin A, De Jongm R, et al. Influence of psy-
chological stress on immune-inflammatory variables in normal humans. Part II: altered
serum concentration of natural anti-inflammatory agents and soluble membrane antigens
of monocytes and T-lymphocytes. Psychiatry Res 1999;85:293-303.
76. Marshall GD, Agarwal SK, Lloyd C, Cohen L, Henninger EM, Morris GJ. Cytokine dys-
regulation associated with exam stress in healthy medical students. Brain Behav Immun
1998;12:297-307.
77. Walker FR, March J, Hodgson DM. Endotoxin exposure in early life alters the develop-
ment of anxiety-like behaviour in the Fischer 344 rat. Behav Brain Res 2004;154:63-69.
78. Gold PW, Chrousos GP. The endocrinology of melancholic and atypical depression:
relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians 1999;
111:22-34.
79. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology
2000;23:477-501.
80. Rubinow DR, Post RM, Savard R, Gold PW. Cortisol hypersecretion and cognitive impair-
ment in depression. Arch Gen Psychiatry 1984;41:279-83.
81. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, et al. Elevated
concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed
patients. Science 1984;226:1342-44.
82. Heuser I, Yassouridis A, Holsboer F. The combined dexamethasone/CRH test: a refined
laboratory test for psychiatric disorders. J Psychiatr Res 1994;28:341-56.
83. Linthorst ACE, Reul JMHM. Inflammation and brain function under basal conditions and
during long-term elevation of brain corticotropin-releasing hormone levels. In: Dantzer R,
Wollmann EE, Yirmiya R, editors. Cytokines, stress and depression. New York: Plenum
Press; 1999. p. 129-52.
84. Walker LG, Walker MB, Heus SD, Lolley J, Wesnes K, Eremin O. The psychological
and psychiatric effects of IL-2 therapy: a controlled clinical trial. Psychooncology 1997;
6:290-301.
85. Meyers CA. Mood and cognitive disorders in cancer patients receiving cytokine therapy.
In: Dantzer R, Wollmann EE, Yirmiya R, editors. Cytokines, stress and depression. New
York: Plenum Press; 1999. p. 75-82.
86. Anisman H, Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. In: Dantzer
R, Wollmann EE, Yirmiya R, editors. Cytokines, stress and depression. New York: Plenum
Press; 1999. p. 199-234.
87. Yirmiya R, Weidenfeld J, Pollak Y, Morag M, Morag A, Avitsur R. Cytokines, “depression
due to a general medical condition” and antidepressant drugs. In: Dantzer R, Wollmann EE,
Search WWH ::




Custom Search